FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration
EpiPen 0.3 mg and EpiPen Jr 0.15 mg auto-injectors, and the authorized generic versions, may potentially have delayed injection or be prevented from properly injecting due to:
Device failure from spontaneous activation caused by using sideways force to remove the blue safety release.
Device failure from inadvertent or spontaneous activation due to a raised blue safety release.
Difficulty removing the device from the carrier tube.